Khan I - Search Results

1

The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor.

Lacombe ML, Lamarche F, De Wever O, Padilla-Benavides T, Carlson A, Khan I, Huna A, Vacher S, Calmel C, Desbourdes C, Cottet-Rousselle C, Hininger-Favier I, Attia S, Nawrocki-Raby B, Raingeaud J, Machon C, Guitton J, Le Gall M, Clary G, Broussard C, Chafey P, Thérond P, Bernard D, Fontaine E, Tokarska-Schlattner M, Steeg P, Bièche I, Schlattner U, Boissan M. Lacombe ML, et al. Among authors: khan i. BMC Biol. 2021 Oct 21;19(1):228. doi: 10.1186/s12915-021-01155-5. BMC Biol. 2021. PMID: 34674701 Free PMC article.

2

Metastasis suppressors: functional pathways.

Khan I, Steeg PS. Khan I, et al. Lab Invest. 2018 Feb;98(2):198-210. doi: 10.1038/labinvest.2017.104. Epub 2017 Oct 2. Lab Invest. 2018. PMID: 28967874 Free PMC article. Review.

3

The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities.

Khan I, Steeg PS. Khan I, et al. Oncotarget. 2017 Dec 31;9(12):10185-10202. doi: 10.18632/oncotarget.23796. eCollection 2018 Feb 13. Oncotarget. 2017. PMID: 29535799 Free PMC article.

4

Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.

Khan I, Gril B, Steeg PS. Khan I, et al. Cancer Res. 2019 Sep 15;79(18):4689-4702. doi: 10.1158/0008-5472.CAN-19-0492. Epub 2019 Jul 16. Cancer Res. 2019. PMID: 31311812 Free PMC article.

5

HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker.

Gril B, Wei D, Zimmer AS, Robinson C, Khan I, Difilippantonio S, Overstreet MG, Steeg PS. Gril B, et al. Among authors: khan i. Neuro Oncol. 2020 Nov 26;22(11):1625-1636. doi: 10.1093/neuonc/noaa118. Neuro Oncol. 2020. PMID: 32386414 Free PMC article.

6

Endocytosis: a pivotal pathway for regulating metastasis.

Khan I, Steeg PS. Khan I, et al. Br J Cancer. 2021 Jan;124(1):66-75. doi: 10.1038/s41416-020-01179-8. Epub 2020 Dec 2. Br J Cancer. 2021. PMID: 33262521 Free PMC article. Review.

7

Keeping brain metastases dormant.

Khan I, Steeg PS. Khan I, et al. Nat Cancer. 2022 Jan;3(1):3-5. doi: 10.1038/s43018-021-00321-6. Nat Cancer. 2022. PMID: 35121997 No abstract available.

8

Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems.

Khan I, Gril B, Hoshino A, Yang HH, Lee MP, Difilippantonio S, Lyden DC, Steeg PS. Khan I, et al. Clin Exp Metastasis. 2022 Oct;39(5):815-831. doi: 10.1007/s10585-022-10182-7. Epub 2022 Aug 8. Clin Exp Metastasis. 2022. PMID: 35939247 Free PMC article.

9

A perspective on the metastasis suppressor field.

Khan I, Steeg PS. Khan I, et al. Cancer Metastasis Rev. 2023 Dec;42(4):1061-1063. doi: 10.1007/s10555-023-10131-0. Cancer Metastasis Rev. 2023. PMID: 37581870 Review.

10

Distinct uptake and elimination profiles for trastuzumab, human IgG and biocytin-TMR in experimental HER2+ brain metastases of breast cancer.

Silvestri VL, Tran AD, Chung M, Chung N, Gril B, Robinson C, Difilippantonio S, Wei D, Kruhlak MJ, Peer CJ, Figg WD, Khan I, Steeg PS. Silvestri VL, et al. Among authors: khan i. Neuro Oncol. 2024 Feb 13:noae025. doi: 10.1093/neuonc/noae025. Online ahead of print. Neuro Oncol. 2024. PMID: 38363979

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,991 results

Search Page